173 related articles for article (PubMed ID: 27400853)
1. Serum α-fetoprotein concentration in extremely low-birthweight infants.
Maruyama K
Pediatr Int; 2017 Feb; 59(2):159-162. PubMed ID: 27400853
[TBL] [Abstract][Full Text] [Related]
2. Alpha-fetoprotein (AFP) levels in normal children.
Ohama K; Nagase H; Ogino K; Tsuchida K; Tanaka M; Kubo M; Horita S; Kawakami K; Ohmori M
Eur J Pediatr Surg; 1997 Oct; 7(5):267-9. PubMed ID: 9402482
[TBL] [Abstract][Full Text] [Related]
3. DLK1, a serum marker for hepatoblastoma in young infants.
Falix FA; Aronson DC; Lamers WH; Hiralall JK; Seppen J
Pediatr Blood Cancer; 2012 Oct; 59(4):743-5. PubMed ID: 22180200
[TBL] [Abstract][Full Text] [Related]
4. Hepatoblastoma in Explanted Livers of Patients With Biliary Atresia.
Amir AZ; Sharma A; Cutz E; Avitzur Y; Shaikh F; Kamath BM; Ling SC; Ghanekar A; Ng VL
J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):188-94. PubMed ID: 27457778
[TBL] [Abstract][Full Text] [Related]
5. The role of subfractionation of alpha-fetoprotein in the treatment of pediatric surgical patients.
Tsuchida Y; Terada M; Honna T; Kitano Y; Obana K; Leibundgut K; Ishiguro T
J Pediatr Surg; 1997 Mar; 32(3):514-7. PubMed ID: 9094031
[TBL] [Abstract][Full Text] [Related]
6. Pretransplant trends in α-fetoprotein levels as a predictor of recurrence after living donor liver transplantation for unresectable hepatoblastoma: A single-institution experience.
Isono K; Ohya Y; Lee KJ; Hashimoto S; Kadohisa M; Sakisaka M; Uto K; Hayashida S; Yamamoto H; Yamamoto H; Sugawara Y; Inomata Y
Pediatr Transplant; 2018 Aug; 22(5):e13221. PubMed ID: 29761829
[TBL] [Abstract][Full Text] [Related]
7. The Utility of Serum Alpha-fetoprotein for Monitoring for Relapse of Alpha-fetoprotein-Positive Hepatoblastoma.
Davini M; Hastings C; Feusner J
J Pediatr Hematol Oncol; 2024 May; 46(4):206-210. PubMed ID: 38551915
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary investigations of the serum alpha-1-fetoprotein level in mature and premature newborn infants (author's transl)].
Bugajer-Gleitman HE; Eder G; Lachmann D; Pollak A
Wien Klin Wochenschr; 1975 Oct; 87(18):601-5. PubMed ID: 56817
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Takahashi Y; Taguchi T
J Pediatr Hematol Oncol; 2008 Jun; 30(6):447-50. PubMed ID: 18525461
[TBL] [Abstract][Full Text] [Related]
10. Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging.
Rojas Y; Guillerman RP; Zhang W; Vasudevan SA; Nuchtern JG; Thompson PA
Pediatr Radiol; 2014 Oct; 44(10):1275-80. PubMed ID: 24839140
[TBL] [Abstract][Full Text] [Related]
11. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
Van Tornout JM; Buckley JD; Quinn JJ; Feusner JH; Krailo MD; King DR; Hammond GD; Ortega JA
J Clin Oncol; 1997 Mar; 15(3):1190-7. PubMed ID: 9060563
[TBL] [Abstract][Full Text] [Related]
12. A case of well-differentiated, fetal-type hepatoblastoma with very low serum alpha-fetoprotein.
Tsuchida Y; Ikeda H; Suzuki N; Takahashi A; Kuroiwa M; Sakai M; Shimizu H; Shitara T; Yamanouchi H; Hirato J
J Pediatr Surg; 1999 Dec; 34(12):1762-4. PubMed ID: 10626849
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
Koh KN; Park M; Kim BE; Bae KW; Kim KM; Im HJ; Seo JJ
Pediatr Blood Cancer; 2011 Oct; 57(4):554-60. PubMed ID: 21370433
[TBL] [Abstract][Full Text] [Related]
14. Hepatoblastoma in a child of extremely low birth weight.
Jaing TH; Hung IJ; Lin JN; Lien RI; Hsueh C; Lu CS
Am J Perinatol; 2002 Apr; 19(3):149-53. PubMed ID: 12012290
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein.
MacDonell-Yilmaz R; Anderson K; DeNardo B; Sprinz P; Padula WV
J Pediatr; 2020 Oct; 225():80-89.e4. PubMed ID: 32470475
[TBL] [Abstract][Full Text] [Related]
16. Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.
Katzenstein HM; Furman WL; Malogolowkin MH; Krailo MD; McCarville MB; Towbin AJ; Tiao GM; Finegold MJ; Ranganathan S; Dunn SP; Langham MR; McGahren ED; Rodriguez-Galindo C; Meyers RL
Cancer; 2017 Jun; 123(12):2360-2367. PubMed ID: 28211941
[TBL] [Abstract][Full Text] [Related]
17. Hepatoblastoma in children of extremely low birth weight: a report from a single perinatal center.
Oue T; Kubota A; Okuyama H; Kawahara H; Nara K; Kawa K; Kitajima H
J Pediatr Surg; 2003 Jan; 38(1):134-7; discussion 134-7. PubMed ID: 12592636
[TBL] [Abstract][Full Text] [Related]
18. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience.
De Ioris M; Brugieres L; Zimmermann A; Keeling J; Brock P; Maibach R; Pritchard J; Shafford L; Zsiros J; Czaudzerna P; Perilongo G
Eur J Cancer; 2008 Mar; 44(4):545-50. PubMed ID: 18166449
[TBL] [Abstract][Full Text] [Related]
19. Treatment of alpha-fetoprotein secreting hepatoblastoma by response of serum alpha-fetoprotein levels: a new concept.
Sayar D; Yaniv I; Goshen Y; Cohen IJ
Pediatr Hematol Oncol; 2001 Dec; 18(8):509-18. PubMed ID: 11764100
[TBL] [Abstract][Full Text] [Related]
20. Serum α-fetoprotein in pediatric oncology: not a children's tale.
Ferraro S; Panzeri A; Braga F; Panteghini M
Clin Chem Lab Med; 2019 May; 57(6):783-797. PubMed ID: 30367785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
